← back to search

Sandrine Paindavoine

Université Claude Bernard Lyon 1 · FR
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Biology, Pathology, Medicine, Cancer research, Computational biology, and Fluorescence in situ hybridization.
h-index
citations
1,028
works
14
NIH funding
primary concept
email

Recent publications

SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors
Modern Pathology 2024cited by 25position: middledoi
Update on gene fusions and the emerging clinicopathological landscape of peritoneal and pleural mesotheliomas and other neoplasms
ESMO Open 2024cited by 12position: middledoi
Recurrent <i>PAK2</i> rearrangements in poroma with folliculo‐sebaceous differentiation
Histopathology 2023cited by 25position: middledoi
Histologic and Genetic Features of 51 Melanocytic Neoplasms With Protein Kinase C Fusion Genes
Modern Pathology 2023cited by 21position: middledoi
Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis
Genes Chromosomes and Cancer 2022cited by 60position: middledoi
A Combination of MTAP and p16 Immunohistochemistry Can Substitute for <i>CDKN2A</i> Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas
Archives of Pathology & Laboratory Medicine 2022cited by 21position: middledoi
Superficial CD34‐positive fibroblastic tumor and <i>PRDM10</i>‐rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases
Histopathology 2021cited by 46position: middledoi
Reply to: Expanding the Spectrum of Primary Cutaneous Carcinoma With BRD3-NUTM1 Fusion
The American Journal of Surgical Pathology 2021cited by 19position: middledoi
SRF Fusions Other Than With RELA Expand the Molecular Definition of SRF-fused Perivascular Tumors
The American Journal of Surgical Pathology 2020cited by 25position: middledoi
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial
Annals of Oncology 2019cited by 189position: middledoi
CYSLTR2-mutant Cutaneous Melanocytic Neoplasms Frequently Simulate “Pigmented Epithelioid Melanocytoma,” Expanding the Morphologic Spectrum of Blue Tumors
The American Journal of Surgical Pathology 2019cited by 28position: middledoi
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration
Acta Neuropathologica 2018cited by 115position: middledoi
Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions
Modern Pathology 2018cited by 80position: middledoi
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
Nature Genetics 2015cited by 362position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel Pissaloux · Université Claude Bernard Lyon 111 papers (2018–2024)Franck Tirode · Cancer Research Center9 papers (2019–2024)Arnaud de la Fouchardière · Université Claude Bernard Lyon 15 papers (2019–2024) · 4 papers (2021–2024)Marie Karanian · Instituto Nacional de Cancerología4 papers (2020–2022) · 3 papers (2019–2024)Thibault Kervarrec · St Thomas' Hospital3 papers (2021–2024)Aurélie Houlier · Université Claude Bernard Lyon 13 papers (2022–2024)Françoise Galateau-Sallé · Centre National de la Recherche Scientifique3 papers (2022–2024)François Le Loarer · Université Claude Bernard Lyon 13 papers (2021–2024)Maxime Battistella · Institut Pasteur3 papers (2021–2024) · 2 papers (2023–2024) · 2 papers (2022–2024)Jean‐Yves Blay · International Network for Economic, Social and Cultural Rights2 papers (2020–2022) · 2 papers (2021–2022) · 2 papers (2023–2024)Nazim Benzerdjeb · Université Claude Bernard Lyon 12 papers (2024–2024)Adeline Duc · Université Claude Bernard Lyon 12 papers (2020–2022)Evelyn Vanesa Erazo Luna · St Thomas' Hospital2 papers (2023–2024)Sylvie Lantuéjoul · Université Claude Bernard Lyon 12 papers (2022–2024)